Through collagen hydroxylase-dependent extracellular matrix remodeling, VC normalizes tumor vasculature to enhance drug delivery while suppressing regulatory T cells (Tregs) and reinvigorating CD8+ T cell cytotoxicity (10). Here, CD8A is linked to neoplasm.